ENTITY
Kolon TissueGene

Kolon TissueGene (950160 KS)

16
Analysis
Health Care • United States
Kolon TissueGene, Inc. operates as a biopharmaceutical company. The Company develops novel advanced orthopedic disorders cell therapies, novel cell and gene therapies drugs, and other related products. Kolon TissueGene offers services worldwide.
more
bearish•CJ ENM
•10 Nov 2017 22:06

CJ E&M Vs. Hanjin Kal - Trade Pattern Analysis Amid Subsidiary IPO

We, Korea, have two major IPOs coming up late this year. They are Studio Dragon Corp (253450 KS) and Jin Air Co., Ltd. (272450 KS). Both are...

Logo
514 Views
Share
•07 Nov 2017 02:29

TissueGene IPO Part 5 - Recap on First Day Trade

TissueGene Inc. (950160 KS)'s opening price was set at ₩52,000. Well, this is a whopping 92.6% up from the IPO price of ₩27,000. Eventually, it...

Logo
399 Views
Share
•19 Oct 2017 22:51

TissueGene IPO Part 4 - Bookbuilding Result Review

Can you believe this?TissueGene Inc. (950160 KS) IPO price was set at ₩27,000. This is the upper end of the indicative price band, ₩16,000 -...

Logo
376 Views
Share
•17 Oct 2017 13:38

TissueGene IPO Part 3 - More Fact Gathering from Yesterday's Press Meeting

It is time to decide on TissueGene Inc. (950160 KS) IPO. Its bookbuilding is actually taking place today and tomorrow. I know this is a very...

Logo
608 Views
Share
•02 Oct 2017 16:28

TissueGene IPO Part 2 - Facts About Cartilage Regeneration & US Clinical Trial

TissueGene Inc. (950160 KS) is 'still' clearly saying that its Invossa (TG-C) has the following three significant features. Requires only a single...

Logo
528 Views
Share
x